TNF and rheumatoid arthritis: Chilton and Collett [3] used a mixed-method research methodology including a postal questionnaire with 109 patients, and one-to-one interviews with seven patients managed by a National Health Service (NHS) rheumatology department, to explore rheumatoid arthritis (RA) patient treatment preferences when faced with three anti-TNF-α parenteral therapy options.